Category: Drug Discovery
Global Drug Discovery
-
Pharmaceuticals Global Market Briefing 2023
... drugs was the largest segment within the pharmaceuticals market accounting for 15.5% followed by oncology drugs at 13.9% and central nervous system drugs at 11.2%. Pharmaceuticals Global Market Briefing 2023 provides strategists, marketers and senior ... Read More
-
Oncology Drugs Global Market Briefing 2023
... market was $28.5 and in terms of global GDP, the market was 0.20%. Oncology drugs was the second largest segment within the market accounting for 13.9% preceded and followed by anti-infective drugs at 15.5% and ... Read More
-
Cardiovascular Drugs Global Market Briefing 2023
... market was $19.8 and in terms of global GDP, the market was 0.14%. Cardiovascular drugs was the fifth largest segment within the market accounting for 9.6% preceded and followed by respiratory diseases drugs at 9.7% ... Read More
-
Metabolic Disorders Drugs Global Market Briefing 2023
... consumption, the market was $11.7 and in terms of global GDP, the market was 0.08%. Metabolic disorders drugs was the seventh largest segment within the market accounting for 5.7% preceded and followed by musculoskeletal disorders ... Read More
-
Anti-Infective Drugs Global Market Briefing 2023
... was $31.8 and in terms of global GDP, the market was 0.23%. Anti-infective drugs was the largest segment within the market accounting for 15.5% followed by oncology drugs at 13.9% and central nervous system drugs ... Read More
-
Genito-Urinary Drugs Global Market Briefing 2023
... market was $5.5 and in terms of global GDP, the market was 0.04%. Genito-urinary drugs was the eleventh largest segment within the market accounting for 2.6% preceded and followed by dermatology drugs at 3.4% and ... Read More
-
Respiratory Diseases Drugs Global Market Briefing 2023
... consumption, the market was $19.8 and in terms of global GDP, the market was 0.14%. Respiratory diseases drugs was the fourth largest segment within the market accounting for 9.7% preceded and followed by central nervous ... Read More
-
Hematology Drugs Global Market Briefing 2023
... market was $4.6 and in terms of global GDP, the market was 0.03%. Hematology drugs was the twelfth largest segment within the market accounting for 2.2% preceded by genito-urinary drugs at 2.6% and dermatology drugs ... Read More
-
Central Nervous System Drugs Global Market Briefing 2023
... per capita consumption, the market was $23.1 and in terms of global GDP, the market was 0.16%. Central nervous system drugs was the third largest segment within the market accounting for 11.2% preceded and followed ... Read More
-
Dermatology Drugs Global Market Briefing 2023
... market was $7.1 and in terms of global GDP, the market was 0.05%. Dermatology drugs was the tenth largest segment within the market accounting for 3.4% preceded and followed by ophthalmology drugs at 3.5% and ... Read More
-
Gastrointestinal Drugs Global Market Briefing 2023
... market was $9.7 and in terms of global GDP, the market was 0.07%. Gastrointestinal drugs was the eighth largest segment within the market accounting for 4.7% preceded and followed by metabolic disorders drugs at 5.7% ... Read More
-
Musculoskeletal Disorders Drugs Global Market Briefing 2023
... consumption, the market was $13.4 and in terms of global GDP, the market was 0.09%. Musculoskeletal disorders drugs was the sixth largest segment within the market accounting for 6.5% preceded and followed by cardiovascular drugs ... Read More
-
Crohn'S Disease Diagnostics and Therapeutics Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... With the rise in COVID-19, the prevalence of other related complications also increased. According to a report by the SECURE-IBD database in January 2022, adverse COVID-19 outcomes were associated with age and other co-morbidities among ... Read More
-
Social Anxiety Disorder (SAD) - Drug Pipeline Landscape, 2023
... environmental factors like inherited traits, brain structure (amygdala may play a role in controlling the fear response), and environment. The main symptoms of social anxiety disorders are a person's inability to work, difficulty maintaining friendships, ... Read More
-
Amyotrophic Lateral Sclerosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 969.3 Million by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2023-2028. Amyotrophic Lateral Sclerosis (ALS) Treatment refers to a degenerative disease that affects the nerve cells in the spinal ... Read More
-
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Other
... epilepsy drugs market size reached US$ 2.16 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.52 Billion by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2023-2028. The rising ... Read More
-
Global Hepatitis B Virus (HBV) Vaccine Market: Analysis By End User (Adult & Pediatric), By Composition (Mono & Combination), By Region (The US, China, EU+UK, Japan & ROW), Size and Trends with Impact of COVID-19 and Forecast up to 2027
... and Forecast up to 2027 The global hepatitis B virus (HBV) vaccine market was valued at US$2.23 billion in 2021, and is predicted to grow to US$3.04 billion in 2027. The hepatitis B virus (HBV) ... Read More
-
Global Glucagon-like Peptide 1 (GLP-1) Market: Analysis By Product (Trulicity, Ozempic, Victoza, Rybelsus and Other GLP 1 Products), By Route of Administration (Injectable and Oral Medication), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027
... and Forecast up to 2027 GLP-1 receptor agonists are a type of non-insulin medication used to treat type 2 diabetes in conjunction with diet and exercise. These medications are used to help lower blood glucose ... Read More
-
Global Follicular Lymphoma Drugs Market Growth (Status and Outlook) 2023-2029
... of white blood cell they affect. Follicular lymphoma is a non-Hodgkin's lymphoma.Drugs for Follicular lymphoma are Anti-CD20 mAbs, Chemotherapy Agents, Kinase Inhibitor, etc. LPI (LP Information)' newest research report, the “Follicular Lymphoma Drugs Industry Forecast” ... Read More
-
Monkeypox Market: Focus on Therapeutics, Vaccines and Diagnostic Kits
... patients, although it is considered to be clinically less severe. Monkeypox has recently emerged as a prominent orthopox virus affecting public health. In May 2022, multiple cases of the disease were reported in several non-endemic ... Read More
-
2023 Global: Alzheimer'S Disease Drug - Innovative Markets Forecast (2029) report
... 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression ... Read More
-
2023 Global: Amyotrophic Lateral Sclerosis (Als) Treatment - Innovative Markets Forecast (2029) report
... data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 ... Read More
-
Alzheimer's Disease- Drug Pipeline Landscape, 2023
... gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ... Read More
-
2023 Global: Artificial Intelligence (Ai) In Drug Discovery - Innovative Markets Forecast (2029) report
... and regional data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions ... Read More
-
Global Acne Therapeutics Market - 2023-2030
... CAGR of 4.7% during the forecast period (2023-2030). Adolescence is the most common time for acne, an inflammatory condition of the pilosebaceous units. Open (black) and closed (white) comedones, inflammatory papules, pustules, nodules, and cysts ... Read More
Research Assistance
